Abstract
A mass fragmentographic method for the quantitation of chlorpromazine (CPZ), monodemethyl-chlorpromazine (nor1-CPZ), and 7-hydroxychlorpromazine (7-OH-CPZ) in plasma, cerebrospinal fluid, and tissues has been developed. The deuterated analogues of the compounds are used as internal standards. The high specificity was ascertained by multiple ion determination. The experimental error is below 10%. The sensitivity allows determination of sub ng quantities of CPZ per ml cerebrospinal fluid. The method has been applied to the analysis of drug concentrations in plasma and cerebrospinal fluid (CSF) of chlorpromazine-treated patients. The amount of CPZ in CSF was about 3% of the plasma level. The CPZ levels in plasma and CSF were significantly correlated.
Similar content being viewed by others
References
Alfredsson, G., Sedvall, G.: Mass fragmentographic analysis of chlorpromazine in human plasma. In: Antipsychotic drugs: pharmacodynamics and pharmacokinetics, G. Sedvall, B. Uvnäs, and Y. Zotterman, eds. Oxford: Pergamon Press (in press, 1976)
Brookes, L.-G., Holmes, M.-A., Forrest, I.-S., Bacon, V.-A., Duffield, A.-M., Solomon, M.-D.: Chlorpromazine metabolism in sheep. II. In vitro metabolism and preparation of 3H-7-hydroxychlorpromazine. Agressologie 12, 333–342 (1971)
Chan, T. L., Sakalis, G., Gershon, S.: Quantitation of chlorpromazine and its metabolites in human plasma and urine by direct spectrodensitometry of thin-layer chromatograms. In: Advances in biochemical psychopharmacology, Vol. 9, I. S. Forrest, C. J. Carr, and E. Usdin, eds., pp. 323–333. New York: Raven Press 1974
Craig, J. C., Mary, N. Y., Roy, S. K.: Application of gas chromatography to the detection of tert-amine oxides. Analyt. Chem. 36, 1142–1143 (1964)
Crane, G. E.: Risks of long-term therapy with neuroleptic drugs. In: Antipsychotic drugs: pharmacodynamics and pharmacokinetics, G. Sedvall, B. Uvnäs, and Y. Zotterman, eds. Oxford: Pergamon Press (in press, 1976)
Curry, S. H.: Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector. Analyt. Chem. 40, 1251–1255 (1968)
Curry, S. H.: Relation between binding to plasma protein, apparent volume of distribution, and rate constants of disposition and elimination for chlorpromazine in three species. J. Pharm. Pharmacol. 24, 818–819 (1972)
Curry, S. H.: Metabolism and kinetics of chlorpromazine in relation to effect. In: Antipsychotic drugs: pharmacodynamics and pharmacokinetics, G. Sedval, B. Uvnäs, and Y. Zotterman, eds., Oxford: Pergamon Press (in press, 1976)
Forrest, I. S., Carr, C. J., Usdin, E.: Phenothiazines and structurally related drugs. In: Advances in biochemical psychopharmacology, Vol. 9. New York: Raven Press 1974
Kaul, P. N., Ticku, M. K., Clark, M. L.: Chlorpromazine metabolism. V. Disposition of free and conjugated metabolism in blood fractions of schizophrenic patients. J. pharm. Sci. 61, 1753–1757 (1972)
Kawashima, K., Dixon, R., Spector, S.: Development of radioimmunoassay for chlorpromazine. Europ. J. Pharmacol. 32, 195–202 (1975)
Loga, S., Curry, S., Lader, M.: Interactions of orphenadrine and phenobarbitone with chlorpromazine: Plasma concentrations and effects in man. Brit. J. clin. Pharmacol. 2, 197–208 (1975)
Mackay, A. V. P., Healey, A. F., Baker, J.: The relationship of plasma chlorpromazine to its 7-hydroxy and sulphoxide metabolites in a large population of chronic schizophrenics. Brit. J. clin. Pharmacol. 1, 425–430 (1974)
Manian, A. A., Piette, L. H., Holland, D., Grover, T., Leterrier, F.: Red blood cell drug binding as a possible mechanism for tranquilization. In: Advances in biochemical psychopharmacology, Vol. 9, I. S. Forrest, C. J. Carr, and E. Usdin, eds., pp. 149–161. New York: Raven Press 1974
Miller, R. J., Iversen, L. L.: Effect of chlorpromazine and same of its metabolites in the dopamine-sensitive adenylate cyclase of rat brain striatum. J. Pharm. Pharmacol. 26, 142–144 (1974)
Nybäck, H., Sedvall, G.: Effect of chlorpromazine and some of its metabolites on synthesis and turnover of catecholamines formed from 14C-tyrosine in mouse brain. Psychopharmacologia (Berl.) 26, 155–160 (1972)
Rivera-Calimlim, L., Castaneda, L., Lasagna, L.: Effects of mode of management on plasma chlorpromazine in psychiatric patients. Clin. Pharmacol. Ther. 14, 978–986 (1973)
Sedvall, G.: Receptor feedback and dopamine turnover in CNS. In: Handbook of psychopharmacology, Vol. 6, L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds., pp. 127–177. New York: Plenum 1975
Wiesel, F.-A., Alfredsson, G.: A mass fragmentographic study on the pharmacokinetics of chlorpromazine and the relation to effects on monoamine metabolism in the rat brain (to be published)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alfredsson, G., Wode-Helgodt, B. & Sedvall, G. A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF. Psychopharmacology 48, 123–131 (1976). https://doi.org/10.1007/BF00423250
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00423250